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Alcohol septal ablation e An evolving procedureAjay Bahl*
Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaAlcohol septal ablation was first reported by Sigwart in 1985.1
Since then the use of this procedure has increased expo-
nentially and today the number of alcohol ablations per-
formed far exceed that of surgical myectomy.2 Alcohol septal
ablation has been reported from Indian centres since the
mid-1990s.3,41. The procedure
There is no standardized protocol for performing alcohol
septal ablation. Procedural variations are being practiced in
different centres. Ideally, each centre should standardize the
protocol and the hardware. Basic steps of the procedure are
described below.
A temporary pacemaker lead is inserted into the right
ventricle and kept in situ for 24e48 h. Baseline hemodynamic
gradients (resting gradients, gradients under Valsalva
maneuver and post-extrasystolic beats) are measured.2. Guide wire
After intravenous heparin an extra-support guide wire is
inserted into the targeted septal. A 90

bend is given to the
distal 3e4 mm of the guide wire tip to help it engage the
septal. An exchange length guide wire is not required.
The procedure can be carried out using the standard 180 cm
guide wire. Once the proximal tip of the guide wire enters the
balloon lumen, the guide wire is lost to the operator tran-
siently. This situation is safe. Since tip of the guide wire is in
the septal artery, there is no risk of distal migration of the
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An over the wire PTCA balloon around 20e30% larger than the
septal artery diameter is passed over the guide wire into the
proximal part of the septal artery. A short balloon of 8e10mm
length is preferred. Since the alcohol enters the septal through
the distal tip of the balloon, a longer balloon may miss out
some branches of the septal artery that arise proximal to the
balloon tip.4. Contrast echocardiography
A baseline contrast echocardiographic study is performed
with the balloon placed in the septal. These images provide
a comparison for the subsequent contrast echo study. This is
important since some areas of the myocardium may be have
greater baseline echogenicity andmay give a false impression
of contrast enhancement in the absence of a baseline study.
The balloon is then inflated to its nominal pressure after
intravenous morphine administration, and the guide wire
pulled out. Contrast angiography of the left anterior
descending artery (LAD) is done to ensure that no contrast
leaks past the balloon into the septal artery. A detailed
contrast echocardiography study is then performed. All 5
views e parasternal long axis, apical long axis, 4 and 5
chamber views and subcostal views are studied. It should be
confirmed that the targeted part of the septum has contrast
enhancement. In the usual left ventricular outflow tract
obstructions (LVOTO) this would mean enhancement of the
septum across the septal-mitral contact point. In addition, the
papillary muscles, apex and right ventricular free wall should
be carefully assessed to confirm that these areas are not
enhanced on contrast echo.y of India. All rights reserved.
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injected through the balloon lumen with force. This serves
three purposes. Firstly, any collaterals or aberrant branch
communicating with an epicardial coronary artery like the
right coronary artery are identified. If these are present then
the procedure should not be carried out. Secondly, the forceful
injection would reveal any backflow across the balloon.
Thirdly if the balloon position is unstable it will slip with the
forceful injection. This is preferred to balloon slippage during
alcohol injection which can result in alcohol entering the LAD
and causing a large myocardial infarction.
Ethanol (>95%) is then injected into the septal. The injec-
tion is slow with 1 ml alcohol injected over a minute. A 1 ml
insulin syringe is ideal for this purpose. An angiogram is done
to demonstrate normal flow in the LAD after injecting 1 ml of
alcohol and at the completion of alcohol injection. Echocar-
diography is again carried out to confirm the location of the
alcohol depot. The balloon is kept inflated for 10 min after the
alcohol injection, then deflated and rapidly pulled out. A final
angiogram is taken to confirm good flow in the LAD and
blockage of the targeted septal and the hemodynamic
measurements repeated.
The patient is observed in hospital for the development of
heart block and arrhythmias for a week, the initial 2e3 days
being in the coronary care unit. The most important compli-
cation associated with the procedure is complete heart block.
With reduction in the volume of alcohol injected, the inci-
dence of heart block has gradually reduced over the years.
Currently around 10% of patients require permanent pace-
maker implantation. An occasional patient with severe dia-
stolic dysfunction may not tolerate the atrio-ventricular
dissociation and develop hemodynamic compromise. These
patients can often be stabilized by restoring atrio-ventricular
synchrony. Thus a dual chamber temporary pacemaker
should be available in catheterization laboratories carrying
out alcohol septal ablation.5. Target artery
The target artery is usually the first septal branch of the LAD.
The target artery should be confirmed by contrast echocardi-
ography. There is a large variation in the size and distribution
of the first septal artery. The first septal artery arises
13e37 mm from the LAD osteum.5 In patients with HCM,
septal artery was larger than 2 mm in diameter in 25%,
1e2mm in 50% and smaller than 1mm in 25%. On autopsy the
first septal supplied right ventricular free wall in 20%.5 This is
clinically important since if not picked up on contrast echo,
ablation of the first septal can result in right ventricular
infarction.6. Which agent for echocardiographic
contrast?
The procedure has evolved over the last 2 decades. The major
trend has been the increasing use of contrast echocardiog-
raphy. The usual radiographic contrast agents are often used
instead of echocardiographic contrast agents to identify thearea of the myocardium perfused by the septal branch. The
radiographic contrast agent is often well visualized on echo-
cardiography in areas with high contrast density like the
septum. However, areas of anomalous supply like the papil-
lary muscle and right ventricular free wall that have a lower
contrast density may not get highlighted with radiographic
contrast agents. Various echocardiographic contrast agents
have been tried for this procedure. Levovist, a first generation
echocardiographic contrast agent is probably the best contrast
agent in highlighting areas supplied by the septal. Levovist
however is not available in many countries including India.
Second generation echo contrast agents are widely available.
These unfortunately are not very suitable for the procedure.
Unlike the first generation agents, the second generation echo
contrast agents pass much more efficiently through the
capillary bed and are thus preferred agents for intravenous
contrast echocardiography.6 This very property that make
them good agents for use as intravenous contrast, make them
less suitable as contrast echo agents in myocardial contrast
echocardiography. Since they rapidly pass through the capil-
lary bed, they do not form a good depot in the myocardium,
instead they rapidly get washed out of themyocardium. There
is clearly a need for better echocardiographic contrast agents
for this procedure. Modified gelatin (4%) is widely available as
a volume expander. It gives good echocardiographic contrast
that is comparable to levovist. If it proves effective with wider
usage, it could be a very cheap and ideal contrast agent for
alcohol ablation.7. Volume of alcohol
The other major change in the procedure is a reduction in the
volume of alcohol used. Currently the recommended volume
of alcohol used is 1e3ml. The usual volume of alcohol injected
into the myocardium usually is around 2 ml. The capacity of
the balloon lumen (around 0.3 ml but may vary for different
balloons) should also be taken into account and added to the
total volume of alcohol injected.8. Septal artery ablation e alternate
techniques
Covered stents, coils and absorbant gelatin sponge particles
have been used to treat LVOTO in patients with HCM though
the experience with these techniques is limited.7e11 Covered
stents are deployed in the LAD across the septal artery osteum
and block the septal flow. Covered stents should no longer be
used in view of high risk of complications like stent throm-
bosis and restenosis and the long term need for anti-platelet
therapy. In addition the septal contractility can recover due
to flow from collaterals resulting in procedural failure.7
Similarly there are concerns regarding coil occlusion of
septal artery. Merely blocking the septal artery will produce
a variable and unpredictable infarction depending on degree
of collateralization of the septum. Therefore, in well-collat-
eralized areas the infarct size may be much smaller than ex-
pected and the underlyingmyocardiummay recover function.
Since the extent of collateralization cannot be predicted,
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other hand, alcohol ablation produces a more predictable
infarction. Echocardiographic contrast injection into theseptal
artery clearly demarcates the area of the septum being
supplied by the target artery. Alcohol produces an infarct not
only by ischemia caused by arterial obstruction but also by
direct cytotoxicity. Thus thedegreeof collateralization ismuch
less likely to affect the infarct size with alcohol ablation.129. Alcohol ablation in unusual situations
Alcohol septal ablation is most commonly used in patients
with left ventricular outflow tract obstruction caused by
systolic anterior motion of the mitral valve. There have been
a number of reports where alcohol ablation has been used for
unusual indications. In this issue of the journal Bhagava B et al
have described an interesting case of a patient with HCM in
shock following sepsis and massive gastrointestinal bleed.13
His LVOTO was responsible for the hypotension and he had
immediate improvement in hemodynamics following alcohol
septal ablation. Surgical myectomy would have been a very
high-risk option in view of sepsis with multiorgan dysfunc-
tion. This case highlights the potential role of alcohol septal
ablation in patients who are in shock. Surgical myectomy
however still remains the procedure of choice for patients
with LVOTO who are in shock and at low surgical risk. This is
because clinical and hemodynamic benefit is achieved
immediately after septal myectomy butmay be delayed for up
to 3 months after alcohol septal ablation.14,15 In addition,
there is a risk of increase in gradients in the first few days after
alcohol ablation due to development of myocardial edema at
the ablation site.16 This increase in gradient may not be
tolerated by patients who are already in shock.
Other unusual situations where alcohol ablation has been
successfully carried out include mid-cavity obstruction,17
right ventricular outflow tract obstruction due to idiopathic
infundibular pulmonic stenosis.18
The current status ofmyectomy and alcohol septal ablation
is controversial and has been well debated.2,15 As per current
guidelines surgical myectomy is the gold standard procedure
for treating LVOTO especially in young patients.14 To a large
extent this is because of a long experience of over 50 yearswith
myectomy. Alcohol septal ablation is a relatively new proce-
dure which has been gradually modified over the years. This
procedure has shown good short andmedium term results. As
long term results of alcohol septal ablation become available,
the role of this procedure in the will continue to evolve.r e f e r e n c e s
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